Funder: Food and Drug Administration

Due Dates: Forecasted (no due date posted)

Funding Amounts: Up to $300,000 per award; total program funding $600,000; project period and number of awards not yet finalized.

Summary: Supports development of PBPK model-based mechanistic IVIVCs for long-acting injectable suspensions and implants, linking formulation attributes to in vivo drug release.

Key Information: This is a forecasted opportunity; application details and deadlines are not yet available.